Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-23-009448

Dake Benjamin T sold 10,283 shares at an average $16.28 ($167,416)

  • Dake Benjamin T acquired 10,283 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Dake Benjamin T

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-06 Exercise or conversion : show line 1 in the form 10b5-1 +2,412 $1.74 $4,197 3,703 D
2023-06-06 Exercise or conversion : show line 2 in the form 10b5-1 +7,871 $2.14 $16,844 11,574 D
2023-06-06 Sale : show line 3 in the form 10b5-1 −10,268 $16.28 $167,161 1,306 D
2023-06-06 Sale : show line 4 in the form 10b5-1 −15 $16.98 $255 1,291 D
Open-market sales · 10,283 sh · avg $16.28 · $167,416

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2023-06-06 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −905 6,339 D
2023-06-06 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −1,507 21,095 D
2023-06-06 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −1,018 22,405 D
2023-06-06 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) −6,853 164,461 D
Loading xslF345X04/form4-06082023_060620.xml…